American Journal of Cardiology
Volume 102, Issue 5, Supplement , Pages 38G-41G , 8 September 2008

Percutaneous Coronary Intervention for Myocardial Infarction with Left Ventricular Dysfunction

  • James D. Flaherty, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    • Corresponding Author InformationAddress for reprints: James D. Flaherty, MD, Assistant Professor of Medicine, Division of Cardiology, 251 East Huron Street, Galter 8-130, Chicago, Illinois 60611
    • ,
  • Charles J. Davidson, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    • ,
  • David P. Faxon, MD

      Affiliations

    • Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA

References 

  1. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, et al Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669–677
  2. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation. 1993;88:416–429
  3. Velazquez EJ, Pfeffer MA, McMurray JV, Maggioni AP, Rouleau J-L, Van de Werf F, et al VALsartan In Acute myocardial iNfarcTion trial: baseline characteristics in context. Eur J Heart Fail. 2003;5:537–544
  4. Steg PG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont M-C, Lopez-Sendon J, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2004;109:494–499
  5. Ottervanger JP, van't Hof AWJ, Reiffers S, Hoorntje JCA, Suryapranata H, de Boer MJ, et al. Long-term recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J. 2001;22:785–790
  6. Ross AM, Coyne KS, Moreyra E, Reiner JS, Greenhouse SW, Walker PL, et al. Extended mortality benefit of early postinfarction reperfusion. Circulation. 1998;97:1549–1556
  7. Stenestrand U, Lindback J, Wallentin L RIKS-HIA Registry. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA. 2006;296:1749–1756
  8. Zijlstra F, Hoorntje JCA, de Boer MJ, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1999;341:1413–1419
  9. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13–20
  10. Sheiban I, Fragasso G, Rosano GMC, Dharmadhikari A, Tzifos V, Pagnotta P, et al. Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol. 2001;38:464–471
  11. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, et al ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: summary article. J Am Coll Cardiol. 2006;47:216–235
  12. Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR. Cardiogenic shock complicating acute coronary syndromes. Lancet. 2000;356:749–756
  13. Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, et al One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190–192
  14. Puma JA, Sketch MH, Thompson TD, Simes RJ, Morris DC, White HD, et al. Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. Am J Cardiol. 1999;83:482–487
  15. Rott D, Behar S, Hod H, Feinberg MS, Boyko V, Mandelzweig L, et al. Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures. Am Heart J. 2001;141:267–276
  16. Patel TN, Bavry AA, Kumbhani DJ, Ellis SG. A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol. 2006;97:1685–1690
  17. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395–2407
  18. Clappers N, Verheugt FWA. Hotline session of the 28th European Congress of Cardiology/World Congress of Cardiology 2006. Eur Heart J. 2006;27:2896–2899
  19. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007;297:1985–1991
  20. Bavry AA, Kumbhani DJ, Rassi AN, Bhatt DL, Askari AT. Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol. 2006;48:1319–1325
  21. Khot UN, Jia G, Moliterno DJ, Lincoff AM, Khot MB, Harrington RA, et al. Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification. JAMA. 2003;290:2174–2181
  22. Rott D, Behar S, Leor J, Hod H, Boyko V, Mandelzweig L, et al. Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures. Am J Cardiol. 2001;88:618–623
  23. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice M-C, et al Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356:998–1008
  24. Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J. 2006;27:2784–2814
  25. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130
  26. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, et al Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159–168
  27. Baks T, van Geuns R-J, Biagini E, Wielopolski P, Mollet NR, Cademartiri F, et al. Recovery of left ventricular function after primary angioplasty for acute myocardial infarction. Eur Heart J. 2005;26:1070–1077
  28. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. J Am Coll Cardiol. 2004;44:e213–e310
  29. Thiele H, Sick P, Boudriot E, Diederich K-W, Hambrecht R, Niebauer J, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276–1283
  30. Byrne JG, Leacche M, Unic D, Rawn JD, Simon DI, Rogers CD, et al. Staged initial percutaneous coronary intervention followed by valve surgery (“hybrid approach”) for patients with complex coronary and valve disease. J Am Coll Cardiol. 2005;45:14–18
  31. Waksman R. Biodegradable stents: they do their job and disappear. J Invasive Cardiol. 2006;18:70–74
  32. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, et al Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet. 2007;369:1869–1875

 Statement of author disclosure: Please see the Author Disclosures section at the end of this article.

PII: S0002-9149(08)00999-5

doi: 10.1016/j.amjcard.2008.06.009

American Journal of Cardiology
Volume 102, Issue 5, Supplement , Pages 38G-41G , 8 September 2008

Article Tools